409 related articles for article (PubMed ID: 15985581)
1. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
Mikdashi J; Krumholz A; Handwerger B
Neurology; 2005 Jun; 64(12):2102-7. PubMed ID: 15985581
[TBL] [Abstract][Full Text] [Related]
2. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
Mikdashi J; Handwerger B
Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
[TBL] [Abstract][Full Text] [Related]
7. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
To CH; Petri M
Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
[TBL] [Abstract][Full Text] [Related]
8. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
9. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
Hanly JG; Robichaud J; Fisk JD
J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
[TBL] [Abstract][Full Text] [Related]
10. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
Fragoso-Loyo HE; Sánchez-Guerrero J
J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors.
Calvo-Alen J; Alarcon GS; Burgard SL; Burst N; Bartolucci AA; Williams HJ
J Rheumatol; 1996 Mar; 23(3):469-75. PubMed ID: 8832985
[TBL] [Abstract][Full Text] [Related]
12. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
Wang M; Gladman DD; Ibañez D; Urowitz MB
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients.
Zhou HQ; Zhang FC; Tian XP; Leng XM; Lu JJ; Zhao Y; Tang FL; Zhang X; Zeng XF; Zhang ZL; Zhang W; Dong Y
Lupus; 2008 Feb; 17(2):93-9. PubMed ID: 18250131
[TBL] [Abstract][Full Text] [Related]
15. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
Santos MJ; Vinagre F; Nero P; Barcelos F; Barcelos A; Rodrigues AM; de Matos AA; Silva C; Miranda L; Capela S; Marques A; Branco J; da Silva JC
Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
[TBL] [Abstract][Full Text] [Related]
17. Familiality and co-occurrence of clinical features of systemic lupus erythematosus.
Tsao BP; Grossman JM; Riemekasten G; Strong N; Kalsi J; Wallace DJ; Chen CJ; Lau CS; Ginzler EM; Goldstein R; Kalunian KC; Harley JB; Arnett FC; Hahn BH; Cantor RM
Arthritis Rheum; 2002 Oct; 46(10):2678-85. PubMed ID: 12384927
[TBL] [Abstract][Full Text] [Related]
18. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
[TBL] [Abstract][Full Text] [Related]
19. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
20. Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients.
Govoni M; Bombardieri S; Bortoluzzi A; Caniatti L; Casu C; Conti F; De Vita S; Doria A; Farina I; Ferraccioli G; Gremese E; Mansutti E; Mosca M; Padovan M; Piga M; Tincani A; Tola MR; Tomietto P; Taglietti M; Trotta F; Valesini G; Zen M; Mathieu A;
Rheumatology (Oxford); 2012 Jan; 51(1):157-68. PubMed ID: 22075066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
